nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC22A7—Methotrexate—muscle cancer	0.161	0.233	CbGbCtD
Zalcitabine—CYP3A7—Vincristine—muscle cancer	0.103	0.149	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.103	0.149	CbGbCtD
Zalcitabine—CYP3A5—Vincristine—muscle cancer	0.0774	0.112	CbGbCtD
Zalcitabine—CYP3A5—Etoposide—muscle cancer	0.071	0.103	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—muscle cancer	0.0685	0.0992	CbGbCtD
Zalcitabine—CYP3A4—Vincristine—muscle cancer	0.0302	0.0437	CbGbCtD
Zalcitabine—CYP2D6—Doxorubicin—muscle cancer	0.0297	0.043	CbGbCtD
Zalcitabine—CYP3A4—Etoposide—muscle cancer	0.0277	0.0401	CbGbCtD
Zalcitabine—CYP3A4—Doxorubicin—muscle cancer	0.0189	0.0273	CbGbCtD
Zalcitabine—DCK—Epirubicin—Doxorubicin—muscle cancer	0.00419	1	CbGdCrCtD
Zalcitabine—CYP3A43—testis—muscle cancer	0.00189	0.0916	CbGeAlD
Zalcitabine—SLC29A2—cardiac atrium—muscle cancer	0.00169	0.0818	CbGeAlD
Zalcitabine—SLC29A2—tendon—muscle cancer	0.00147	0.0713	CbGeAlD
Zalcitabine—SLC29A2—vagina—muscle cancer	0.00137	0.0662	CbGeAlD
Zalcitabine—SLC22A7—renal system—muscle cancer	0.00121	0.0587	CbGeAlD
Zalcitabine—DCK—embryo—muscle cancer	0.00118	0.0572	CbGeAlD
Zalcitabine—SLC29A1—renal system—muscle cancer	0.000936	0.0453	CbGeAlD
Zalcitabine—SLC29A1—cardiac atrium—muscle cancer	0.000839	0.0406	CbGeAlD
Zalcitabine—DCK—cardiac atrium—muscle cancer	0.000801	0.0388	CbGeAlD
Zalcitabine—SLC22A7—testis—muscle cancer	0.000784	0.0379	CbGeAlD
Zalcitabine—SLC29A1—tendon—muscle cancer	0.000731	0.0354	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—muscle cancer	0.000708	0.0343	CbGeAlD
Zalcitabine—DCK—tendon—muscle cancer	0.000698	0.0338	CbGeAlD
Zalcitabine—SLC29A1—vagina—muscle cancer	0.000678	0.0328	CbGeAlD
Zalcitabine—DCK—bone marrow—muscle cancer	0.000676	0.0327	CbGeAlD
Zalcitabine—DCK—vagina—muscle cancer	0.000648	0.0313	CbGeAlD
Zalcitabine—SLC29A1—head—muscle cancer	0.000627	0.0303	CbGeAlD
Zalcitabine—SLC29A1—testis—muscle cancer	0.000605	0.0293	CbGeAlD
Zalcitabine—Bladder pain—Doxorubicin—muscle cancer	0.000605	0.00213	CcSEcCtD
Zalcitabine—Convulsion—Vincristine—muscle cancer	0.000603	0.00212	CcSEcCtD
Zalcitabine—Flushing—Etoposide—muscle cancer	0.000601	0.00211	CcSEcCtD
Zalcitabine—Hypertension—Vincristine—muscle cancer	0.000601	0.00211	CcSEcCtD
Zalcitabine—DCK—head—muscle cancer	0.000598	0.029	CbGeAlD
Zalcitabine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000595	0.00209	CcSEcCtD
Zalcitabine—Myalgia—Vincristine—muscle cancer	0.000593	0.00208	CcSEcCtD
Zalcitabine—Hypertonia—Doxorubicin—muscle cancer	0.000587	0.00206	CcSEcCtD
Zalcitabine—Abnormal vision—Doxorubicin—muscle cancer	0.000584	0.00205	CcSEcCtD
Zalcitabine—Chills—Etoposide—muscle cancer	0.000581	0.00204	CcSEcCtD
Zalcitabine—Mental disability—Doxorubicin—muscle cancer	0.000581	0.00204	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000579	0.00204	CcSEcCtD
Zalcitabine—DCK—testis—muscle cancer	0.000578	0.028	CbGeAlD
Zalcitabine—Alopecia—Etoposide—muscle cancer	0.000573	0.00201	CcSEcCtD
Zalcitabine—Lymphadenopathy—Doxorubicin—muscle cancer	0.000569	0.002	CcSEcCtD
Zalcitabine—Oedema—Vincristine—muscle cancer	0.000568	0.002	CcSEcCtD
Zalcitabine—Infection—Vincristine—muscle cancer	0.000565	0.00199	CcSEcCtD
Zalcitabine—Osteoarthritis—Methotrexate—muscle cancer	0.000561	0.00197	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000559	0.00196	CcSEcCtD
Zalcitabine—Diabetes mellitus—Doxorubicin—muscle cancer	0.000559	0.00196	CcSEcCtD
Zalcitabine—Thrombocytopenia—Vincristine—muscle cancer	0.000556	0.00196	CcSEcCtD
Zalcitabine—Decreased appetite—Dactinomycin—muscle cancer	0.000553	0.00194	CcSEcCtD
Zalcitabine—Dysgeusia—Etoposide—muscle cancer	0.000552	0.00194	CcSEcCtD
Zalcitabine—Hyperhidrosis—Vincristine—muscle cancer	0.000549	0.00193	CcSEcCtD
Zalcitabine—Fatigue—Dactinomycin—muscle cancer	0.000548	0.00193	CcSEcCtD
Zalcitabine—Back pain—Etoposide—muscle cancer	0.000546	0.00192	CcSEcCtD
Zalcitabine—Pain—Dactinomycin—muscle cancer	0.000544	0.00191	CcSEcCtD
Zalcitabine—Vascular purpura—Doxorubicin—muscle cancer	0.000543	0.00191	CcSEcCtD
Zalcitabine—Muscle spasms—Etoposide—muscle cancer	0.000542	0.00191	CcSEcCtD
Zalcitabine—Anorexia—Vincristine—muscle cancer	0.000542	0.0019	CcSEcCtD
Zalcitabine—Eye pain—Doxorubicin—muscle cancer	0.000538	0.00189	CcSEcCtD
Zalcitabine—Mood swings—Methotrexate—muscle cancer	0.000531	0.00187	CcSEcCtD
Zalcitabine—Ataxia—Methotrexate—muscle cancer	0.000528	0.00186	CcSEcCtD
Zalcitabine—Renal failure acute—Doxorubicin—muscle cancer	0.000526	0.00185	CcSEcCtD
Zalcitabine—Feeling abnormal—Dactinomycin—muscle cancer	0.000524	0.00184	CcSEcCtD
Zalcitabine—Ill-defined disorder—Etoposide—muscle cancer	0.000523	0.00184	CcSEcCtD
Zalcitabine—Anaemia—Etoposide—muscle cancer	0.000521	0.00183	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00052	0.00183	CcSEcCtD
Zalcitabine—Hot flush—Doxorubicin—muscle cancer	0.000519	0.00183	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000518	0.00182	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000515	0.00181	CcSEcCtD
Zalcitabine—Menopausal symptoms—Doxorubicin—muscle cancer	0.000515	0.00181	CcSEcCtD
Zalcitabine—Insomnia—Vincristine—muscle cancer	0.000514	0.00181	CcSEcCtD
Zalcitabine—Renal impairment—Doxorubicin—muscle cancer	0.00051	0.0018	CcSEcCtD
Zalcitabine—Malaise—Etoposide—muscle cancer	0.000509	0.00179	CcSEcCtD
Zalcitabine—Dermatitis bullous—Doxorubicin—muscle cancer	0.000508	0.00179	CcSEcCtD
Zalcitabine—Vertigo—Etoposide—muscle cancer	0.000507	0.00178	CcSEcCtD
Zalcitabine—Leukopenia—Etoposide—muscle cancer	0.000505	0.00178	CcSEcCtD
Zalcitabine—Purpura—Doxorubicin—muscle cancer	0.000504	0.00177	CcSEcCtD
Zalcitabine—Body temperature increased—Dactinomycin—muscle cancer	0.000503	0.00177	CcSEcCtD
Zalcitabine—Abdominal pain—Dactinomycin—muscle cancer	0.000503	0.00177	CcSEcCtD
Zalcitabine—Cardiac failure—Doxorubicin—muscle cancer	0.000498	0.00175	CcSEcCtD
Zalcitabine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000498	0.00175	CcSEcCtD
Zalcitabine—Loss of consciousness—Etoposide—muscle cancer	0.000496	0.00174	CcSEcCtD
Zalcitabine—Decreased appetite—Vincristine—muscle cancer	0.000494	0.00174	CcSEcCtD
Zalcitabine—Cough—Etoposide—muscle cancer	0.000492	0.00173	CcSEcCtD
Zalcitabine—Fatigue—Vincristine—muscle cancer	0.00049	0.00172	CcSEcCtD
Zalcitabine—Convulsion—Etoposide—muscle cancer	0.000489	0.00172	CcSEcCtD
Zalcitabine—Hyponatraemia—Doxorubicin—muscle cancer	0.000488	0.00172	CcSEcCtD
Zalcitabine—Hypertension—Etoposide—muscle cancer	0.000487	0.00171	CcSEcCtD
Zalcitabine—Pain—Vincristine—muscle cancer	0.000486	0.00171	CcSEcCtD
Zalcitabine—Osteoarthritis—Doxorubicin—muscle cancer	0.000486	0.00171	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000486	0.00171	CcSEcCtD
Zalcitabine—Pain in extremity—Doxorubicin—muscle cancer	0.000486	0.00171	CcSEcCtD
Zalcitabine—Eosinophilia—Methotrexate—muscle cancer	0.00048	0.00169	CcSEcCtD
Zalcitabine—Affect lability—Doxorubicin—muscle cancer	0.000478	0.00168	CcSEcCtD
Zalcitabine—Migraine—Doxorubicin—muscle cancer	0.000478	0.00168	CcSEcCtD
Zalcitabine—Pancreatitis—Methotrexate—muscle cancer	0.000475	0.00167	CcSEcCtD
Zalcitabine—Discomfort—Etoposide—muscle cancer	0.000474	0.00167	CcSEcCtD
Zalcitabine—Hypersensitivity—Dactinomycin—muscle cancer	0.000469	0.00165	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Vincristine—muscle cancer	0.000465	0.00163	CcSEcCtD
Zalcitabine—Confusional state—Etoposide—muscle cancer	0.000464	0.00163	CcSEcCtD
Zalcitabine—CYP3A5—renal system—muscle cancer	0.000463	0.0224	CbGeAlD
Zalcitabine—Mood swings—Doxorubicin—muscle cancer	0.00046	0.00162	CcSEcCtD
Zalcitabine—Infection—Etoposide—muscle cancer	0.000457	0.00161	CcSEcCtD
Zalcitabine—Ataxia—Doxorubicin—muscle cancer	0.000457	0.00161	CcSEcCtD
Zalcitabine—Asthenia—Dactinomycin—muscle cancer	0.000456	0.0016	CcSEcCtD
Zalcitabine—Blood creatinine increased—Doxorubicin—muscle cancer	0.000455	0.0016	CcSEcCtD
Zalcitabine—Dysuria—Methotrexate—muscle cancer	0.000453	0.00159	CcSEcCtD
Zalcitabine—Neutropenia—Methotrexate—muscle cancer	0.000453	0.00159	CcSEcCtD
Zalcitabine—Thrombocytopenia—Etoposide—muscle cancer	0.000451	0.00159	CcSEcCtD
Zalcitabine—Tachycardia—Etoposide—muscle cancer	0.000449	0.00158	CcSEcCtD
Zalcitabine—Abdominal pain—Vincristine—muscle cancer	0.000449	0.00158	CcSEcCtD
Zalcitabine—Body temperature increased—Vincristine—muscle cancer	0.000449	0.00158	CcSEcCtD
Zalcitabine—Skin disorder—Etoposide—muscle cancer	0.000447	0.00157	CcSEcCtD
Zalcitabine—Dry skin—Doxorubicin—muscle cancer	0.000445	0.00157	CcSEcCtD
Zalcitabine—Hyperhidrosis—Etoposide—muscle cancer	0.000445	0.00157	CcSEcCtD
Zalcitabine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000444	0.00156	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000443	0.00156	CcSEcCtD
Zalcitabine—Hypokalaemia—Doxorubicin—muscle cancer	0.000442	0.00155	CcSEcCtD
Zalcitabine—Anorexia—Etoposide—muscle cancer	0.000439	0.00154	CcSEcCtD
Zalcitabine—Diarrhoea—Dactinomycin—muscle cancer	0.000435	0.00153	CcSEcCtD
Zalcitabine—Nasopharyngitis—Doxorubicin—muscle cancer	0.000434	0.00153	CcSEcCtD
Zalcitabine—Depression—Methotrexate—muscle cancer	0.000431	0.00152	CcSEcCtD
Zalcitabine—Gastritis—Doxorubicin—muscle cancer	0.00043	0.00151	CcSEcCtD
Zalcitabine—Muscular weakness—Doxorubicin—muscle cancer	0.000428	0.00151	CcSEcCtD
Zalcitabine—Abdominal distension—Doxorubicin—muscle cancer	0.000423	0.00149	CcSEcCtD
Zalcitabine—Dysphagia—Doxorubicin—muscle cancer	0.00042	0.00148	CcSEcCtD
Zalcitabine—Hypersensitivity—Vincristine—muscle cancer	0.000419	0.00147	CcSEcCtD
Zalcitabine—Eosinophilia—Doxorubicin—muscle cancer	0.000416	0.00146	CcSEcCtD
Zalcitabine—Pancreatitis—Doxorubicin—muscle cancer	0.000412	0.00145	CcSEcCtD
Zalcitabine—Dyspnoea—Etoposide—muscle cancer	0.00041	0.00144	CcSEcCtD
Zalcitabine—Somnolence—Etoposide—muscle cancer	0.000409	0.00144	CcSEcCtD
Zalcitabine—Epistaxis—Methotrexate—muscle cancer	0.000408	0.00143	CcSEcCtD
Zalcitabine—Asthenia—Vincristine—muscle cancer	0.000408	0.00143	CcSEcCtD
Zalcitabine—Vomiting—Dactinomycin—muscle cancer	0.000404	0.00142	CcSEcCtD
Zalcitabine—Rash—Dactinomycin—muscle cancer	0.000401	0.00141	CcSEcCtD
Zalcitabine—Decreased appetite—Etoposide—muscle cancer	0.0004	0.00141	CcSEcCtD
Zalcitabine—Fatigue—Etoposide—muscle cancer	0.000397	0.0014	CcSEcCtD
Zalcitabine—Pain—Etoposide—muscle cancer	0.000394	0.00138	CcSEcCtD
Zalcitabine—Dysuria—Doxorubicin—muscle cancer	0.000393	0.00138	CcSEcCtD
Zalcitabine—Neutropenia—Doxorubicin—muscle cancer	0.000393	0.00138	CcSEcCtD
Zalcitabine—Diarrhoea—Vincristine—muscle cancer	0.000389	0.00137	CcSEcCtD
Zalcitabine—Hepatitis—Methotrexate—muscle cancer	0.000388	0.00136	CcSEcCtD
Zalcitabine—Pollakiuria—Doxorubicin—muscle cancer	0.000388	0.00136	CcSEcCtD
Zalcitabine—Pharyngitis—Methotrexate—muscle cancer	0.000385	0.00135	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000383	0.00135	CcSEcCtD
Zalcitabine—Weight decreased—Doxorubicin—muscle cancer	0.00038	0.00134	CcSEcCtD
Zalcitabine—Feeling abnormal—Etoposide—muscle cancer	0.000379	0.00133	CcSEcCtD
Zalcitabine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000379	0.00133	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Etoposide—muscle cancer	0.000376	0.00132	CcSEcCtD
Zalcitabine—Dizziness—Vincristine—muscle cancer	0.000376	0.00132	CcSEcCtD
Zalcitabine—Visual impairment—Methotrexate—muscle cancer	0.000374	0.00132	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000367	0.00129	CcSEcCtD
Zalcitabine—Urticaria—Etoposide—muscle cancer	0.000366	0.00129	CcSEcCtD
Zalcitabine—Jaundice—Doxorubicin—muscle cancer	0.000365	0.00128	CcSEcCtD
Zalcitabine—Body temperature increased—Etoposide—muscle cancer	0.000364	0.00128	CcSEcCtD
Zalcitabine—Abdominal pain—Etoposide—muscle cancer	0.000364	0.00128	CcSEcCtD
Zalcitabine—Eye disorder—Methotrexate—muscle cancer	0.000363	0.00128	CcSEcCtD
Zalcitabine—Tinnitus—Methotrexate—muscle cancer	0.000362	0.00127	CcSEcCtD
Zalcitabine—Vomiting—Vincristine—muscle cancer	0.000361	0.00127	CcSEcCtD
Zalcitabine—Rash—Vincristine—muscle cancer	0.000358	0.00126	CcSEcCtD
Zalcitabine—Dermatitis—Vincristine—muscle cancer	0.000358	0.00126	CcSEcCtD
Zalcitabine—Headache—Vincristine—muscle cancer	0.000356	0.00125	CcSEcCtD
Zalcitabine—Epistaxis—Doxorubicin—muscle cancer	0.000353	0.00124	CcSEcCtD
Zalcitabine—Sinusitis—Doxorubicin—muscle cancer	0.000351	0.00124	CcSEcCtD
Zalcitabine—Chills—Methotrexate—muscle cancer	0.000348	0.00122	CcSEcCtD
Zalcitabine—CYP3A4—renal system—muscle cancer	0.000348	0.0168	CbGeAlD
Zalcitabine—Alopecia—Methotrexate—muscle cancer	0.000343	0.00121	CcSEcCtD
Zalcitabine—CYP2D6—renal system—muscle cancer	0.000342	0.0165	CbGeAlD
Zalcitabine—Hypersensitivity—Etoposide—muscle cancer	0.000339	0.00119	CcSEcCtD
Zalcitabine—Rhinitis—Doxorubicin—muscle cancer	0.000337	0.00118	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—muscle cancer	0.000336	0.00118	CcSEcCtD
Zalcitabine—CYP3A5—vagina—muscle cancer	0.000336	0.0162	CbGeAlD
Zalcitabine—Pharyngitis—Doxorubicin—muscle cancer	0.000334	0.00117	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—muscle cancer	0.000331	0.00116	CcSEcCtD
Zalcitabine—Asthenia—Etoposide—muscle cancer	0.00033	0.00116	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—muscle cancer	0.000327	0.00115	CcSEcCtD
Zalcitabine—Pruritus—Etoposide—muscle cancer	0.000326	0.00115	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—muscle cancer	0.000324	0.00114	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—muscle cancer	0.000318	0.00112	CcSEcCtD
Zalcitabine—Diarrhoea—Etoposide—muscle cancer	0.000315	0.00111	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—muscle cancer	0.000314	0.0011	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—muscle cancer	0.000313	0.0011	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—muscle cancer	0.000313	0.0011	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—muscle cancer	0.000312	0.0011	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—muscle cancer	0.000312	0.0011	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—muscle cancer	0.000305	0.00107	CcSEcCtD
Zalcitabine—Dizziness—Etoposide—muscle cancer	0.000304	0.00107	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—muscle cancer	0.000304	0.00107	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—muscle cancer	0.000302	0.00106	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—muscle cancer	0.000302	0.00106	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—muscle cancer	0.0003	0.00106	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—muscle cancer	0.000297	0.00104	CcSEcCtD
Zalcitabine—Cough—Methotrexate—muscle cancer	0.000295	0.00104	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—muscle cancer	0.000293	0.00103	CcSEcCtD
Zalcitabine—Vomiting—Etoposide—muscle cancer	0.000293	0.00103	CcSEcCtD
Zalcitabine—Rash—Etoposide—muscle cancer	0.00029	0.00102	CcSEcCtD
Zalcitabine—Dermatitis—Etoposide—muscle cancer	0.00029	0.00102	CcSEcCtD
Zalcitabine—Headache—Etoposide—muscle cancer	0.000288	0.00101	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—muscle cancer	0.000288	0.00101	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—muscle cancer	0.000288	0.00101	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—muscle cancer	0.000288	0.00101	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—muscle cancer	0.000287	0.00101	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—muscle cancer	0.000286	0.00101	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—muscle cancer	0.000284	0.000999	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—muscle cancer	0.000284	0.000999	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—muscle cancer	0.000283	0.000995	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—muscle cancer	0.000281	0.000989	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—muscle cancer	0.000278	0.000978	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—muscle cancer	0.000276	0.00097	CcSEcCtD
Zalcitabine—Infection—Methotrexate—muscle cancer	0.000274	0.000963	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000271	0.000955	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—muscle cancer	0.00027	0.000951	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—muscle cancer	0.00027	0.000949	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—muscle cancer	0.000269	0.000945	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—muscle cancer	0.000268	0.000942	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—muscle cancer	0.000267	0.000937	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—muscle cancer	0.000264	0.000928	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—muscle cancer	0.000263	0.000924	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—muscle cancer	0.000263	0.000924	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—muscle cancer	0.000262	0.000923	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—muscle cancer	0.000262	0.000921	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—muscle cancer	0.000259	0.000909	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—muscle cancer	0.000257	0.000904	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—muscle cancer	0.000255	0.000898	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—muscle cancer	0.000253	0.000891	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—muscle cancer	0.000253	0.000888	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000251	0.000883	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—muscle cancer	0.000249	0.000877	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—muscle cancer	0.000249	0.000876	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—muscle cancer	0.000249	0.000876	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—muscle cancer	0.000248	0.000873	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—muscle cancer	0.000246	0.000865	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—muscle cancer	0.000246	0.000865	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—muscle cancer	0.000245	0.000862	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—muscle cancer	0.000244	0.000857	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—muscle cancer	0.000243	0.000854	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—muscle cancer	0.000241	0.000847	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—muscle cancer	0.00024	0.000843	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—muscle cancer	0.000239	0.00084	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—muscle cancer	0.000238	0.000836	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—muscle cancer	0.000237	0.000834	CcSEcCtD
Zalcitabine—Pain—Methotrexate—muscle cancer	0.000236	0.000829	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—muscle cancer	0.000235	0.000826	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000234	0.000822	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—muscle cancer	0.000233	0.000819	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—muscle cancer	0.000232	0.000816	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000231	0.000812	CcSEcCtD
Zalcitabine—CYP2D6—head—muscle cancer	0.000229	0.0111	CbGeAlD
Zalcitabine—Anorexia—Doxorubicin—muscle cancer	0.000228	0.0008	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—muscle cancer	0.000227	0.000799	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000225	0.000793	CcSEcCtD
Zalcitabine—CYP2D6—testis—muscle cancer	0.000221	0.0107	CbGeAlD
Zalcitabine—Urticaria—Methotrexate—muscle cancer	0.000219	0.00077	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—muscle cancer	0.000218	0.000767	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—muscle cancer	0.000218	0.000767	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000218	0.000765	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—muscle cancer	0.000216	0.000759	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—muscle cancer	0.000213	0.000749	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—muscle cancer	0.000212	0.000746	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—muscle cancer	0.00021	0.000739	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—muscle cancer	0.000208	0.00073	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—muscle cancer	0.000206	0.000724	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—muscle cancer	0.000204	0.000718	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—muscle cancer	0.000203	0.000714	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—muscle cancer	0.000198	0.000696	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—muscle cancer	0.000197	0.000692	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000195	0.000687	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—muscle cancer	0.000195	0.000686	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—muscle cancer	0.00019	0.000667	CcSEcCtD
Zalcitabine—Abdominal pain—Doxorubicin—muscle cancer	0.000189	0.000664	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—muscle cancer	0.000189	0.000664	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—muscle cancer	0.000189	0.000663	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—muscle cancer	0.000182	0.000641	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—muscle cancer	0.000176	0.000619	CcSEcCtD
Zalcitabine—Vomiting—Methotrexate—muscle cancer	0.000175	0.000617	CcSEcCtD
Zalcitabine—Rash—Methotrexate—muscle cancer	0.000174	0.000611	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—muscle cancer	0.000174	0.000611	CcSEcCtD
Zalcitabine—Headache—Methotrexate—muscle cancer	0.000173	0.000607	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—muscle cancer	0.000171	0.000602	CcSEcCtD
Zalcitabine—Pruritus—Doxorubicin—muscle cancer	0.000169	0.000594	CcSEcCtD
Zalcitabine—Diarrhoea—Doxorubicin—muscle cancer	0.000163	0.000574	CcSEcCtD
Zalcitabine—Dizziness—Doxorubicin—muscle cancer	0.000158	0.000555	CcSEcCtD
Zalcitabine—Vomiting—Doxorubicin—muscle cancer	0.000152	0.000534	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—muscle cancer	0.000151	0.000529	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—muscle cancer	0.00015	0.000529	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—muscle cancer	0.00015	0.000526	CcSEcCtD
